Insider Transactions in Q2 2021 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
14,708
-56.74%
|
$2,573,900
$175.0 P/Share
|
|
Jun 18
2021
|
Akshay Vaishnaw President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,804
+16.94%
|
$613,808
$52.61 P/Share
|
|
Jun 09
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,734
-25.25%
|
$267,036
$154.0 P/Share
|
|
May 13
2021
|
John Maraganore Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,979
-2.06%
|
$4,451,249
$131.34 P/Share
|
|
May 13
2021
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,979
+12.02%
|
$237,853
$7.1 P/Share
|
|
Apr 21
2021
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
2,732
-4.23%
|
$374,284
$137.08 P/Share
|
|
Apr 20
2021
|
John Maraganore Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,507
-1.69%
|
$998,431
$133.18 P/Share
|
|
Apr 20
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,089
-11.79%
|
$277,837
$133.08 P/Share
|
|
Apr 20
2021
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,351
-8.85%
|
$312,683
$133.12 P/Share
|
|
Apr 20
2021
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,351
-6.15%
|
$312,683
$133.15 P/Share
|
|
Apr 20
2021
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,383
-15.54%
|
$183,939
$133.12 P/Share
|
|
Apr 19
2021
|
John Maraganore Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,236
+6.81%
|
-
|
|
Apr 19
2021
|
Laurie Keating EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,518
+33.53%
|
-
|
|
Apr 19
2021
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,083
+27.54%
|
-
|
|
Apr 19
2021
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
3,706
-4.3%
|
$511,428
$138.26 P/Share
|
|
Apr 19
2021
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
5,083
+18.16%
|
-
|
|
Apr 19
2021
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,518
+50.0%
|
-
|